These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38072378)

  • 41. Prescribing patterns and outcomes of venous thromboembolism prophylaxis in hospitalized medical and cancer patients: Observations from the Ottawa Hospital.
    Budd AC; Rhodes M; Forster AJ; Noghani P; Carrier M; Wells PS
    Thromb Res; 2021 Jan; 197():144-152. PubMed ID: 33217622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
    Chi G; Gibson CM; Hernandez AF; Hull RD; Kazmi SHA; Younes A; Walia SS; Pitliya A; Singh A; Kahe F; Kalayci A; Nafee T; Kerneis M; AlKhalfan F; Cohen AT; Harrington RA; Goldhaber SZ
    Am J Med; 2018 Aug; 131(8):972.e1-972.e7. PubMed ID: 29660351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.
    Parks AL; Auerbach AD; Schnipper JL; Bertram A; Jeon SY; Boyle B; Fang MC; Gadrey SM; Siddiqui ZK; Brotman DJ;
    PLoS One; 2022; 17(5):e0266944. PubMed ID: 35511940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism.
    Leiss W; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Osterwalder J; Frauchiger B; Matter CM; Kucher N; Angelillo-Scherrer A; Cornuz J; Banyai M; Lämmle B; Husmann M; Egloff M; Aschwanden M; Rodondi N; Aujesky D
    J Gen Intern Med; 2015 Jan; 30(1):17-24. PubMed ID: 25143224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.
    Veeranki SP; Xiao Z; Levorsen A; Sinha M; Shah BR
    Am J Cardiovasc Drugs; 2021 Jul; 21(4):443-452. PubMed ID: 33313988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.
    Pandor A; Horner D; Davis S; Goodacre S; Stevens JW; Clowes M; Hunt BJ; Nokes T; Keenan J; de Wit K
    Health Technol Assess; 2019 Dec; 23(63):1-190. PubMed ID: 31851608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bleeding complications in patients on new oral anticoagulants for venous thromboembolism in Kenya.
    Obayo A; Ngunga M; Shah J; Sokwala A; Barasa A
    Cardiovasc J Afr; 2022 Jul-Aug 23; 33(4):186-192. PubMed ID: 35118489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction.
    Salisbury AC; Alexander KP; Reid KJ; Masoudi FA; Rathore SS; Wang TY; Bach RG; Marso SP; Spertus JA; Kosiborod M
    Circ Cardiovasc Qual Outcomes; 2010 Jul; 3(4):337-46. PubMed ID: 20488919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venous thromboembolism risk and prophylaxis in hospitalized obstetric patients at a tertiary hospital in Accra, Ghana: A comparative cross-sectional study.
    Sefogah PE; Nuamah MA; Swarray-Deen A; Mumuni K; Onuzo CN; Seffah JD
    Int J Gynaecol Obstet; 2021 Jun; 153(3):514-519. PubMed ID: 33249576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decision-analysis modeling of effectiveness and cost-effectiveness of pharmacologic thromboprophylaxis for surgical inpatients using variable risk assessment models or other strategies.
    Davis S; Goodacre S; Horner D; Pandor A; Griffin XL; de Wit K; Hunt BJ; Holland M
    J Thromb Haemost; 2023 Jun; 21(6):1580-1591. PubMed ID: 36863566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis.
    Patell R; Chiasakul T; Bauer E; Zwicker JI
    Thromb Haemost; 2021 Jan; 121(1):76-85. PubMed ID: 33378787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis.
    Presume J; Ferreira J; Ribeiras R; Mendes M
    J Thromb Haemost; 2022 Dec; 20(12):2930-2938. PubMed ID: 36128769
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
    Raskob G; Ageno W; Cohen AT; Brekelmans MP; Grosso MA; Segers A; Meyer G; Verhamme P; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR
    Lancet Haematol; 2016 May; 3(5):e228-36. PubMed ID: 27132697
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism.
    Keller K; Münzel T; Hobohm L; Ostad MA
    Int J Cardiol; 2021 Apr; 329():179-184. PubMed ID: 33301828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Venous thromboembolism prophylaxis in Colombian surgical and medical patients: results for Colombia of the ENDORSE study].
    Dennis RJ; Roa JH; Villadiego J; Méndez F; Vieda E; Restrepo H
    Biomedica; 2011 Jun; 31(2):200-8. PubMed ID: 22159536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
    Pariser JJ; Pearce SM; Anderson BB; Packiam VT; Prachand VN; Smith ND; Steinberg GD
    J Urol; 2017 Feb; 197(2):302-307. PubMed ID: 27569434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.